Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Katharina SydowDepartment of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.ORCID 0009-0000-9172-8774
Eyüp DoğanFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Michael SchwabeDepartment of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.
Stefan E HeidenDepartment of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.
Muhammad Moman KhanFaculty of Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany.
Justus U MüllerDepartment of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.ORCID 0009-0000-0546-7273
Jürgen A BohnertFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Daniel BaeckerDepartment of Pharmaceutical and Medicinal Chemistry, Freie Universität Berlin, Berlin, Germany.
Rabea SchlüterImaging Center of the Department of Biology, University of Greifswald, Greifswald, Germany.
Peter SchierackFaculty of Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany.ORCID 0000-0002-6445-3506
Elias EgerDepartment of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.ORCID 0000-0002-5514-8083
Evgeny A IdelevichFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.ORCID 0009-0009-4207-5290
Karsten Becker *Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-6391-1341
Katharina Schaufler *Department of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.ORCID 0000-0002-2669-8799
Funding
Bundesministerium für Forschung, Technologie und Raumfahrt 01KI2410Bundesministerium für Forschung, Technologie und Raumfahrt 13GW0424
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Potential in-host evolution of · full record | OpenQuestion